Πλοήγηση ανά Συγγραφέα "Semoglou, C."

Αποτελέσματα 1-2 από 2

    • Article  

      Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients 

      Fountzilas, George; Polichronis, A.; Katsohis, C.; Gennatas, Constantinos; Toussis, D.; Skarlos, Dimosthenis V.; Kosmidis, Paraskevas A.; Vassilaros, S.; Semoglou, C.; Giannakakis, T.; Fahantidis, E.; Klouvas, G. D.; Tsavaris, N.; Konstantaras, C.; Makrantonakis, P.; Kolotas, C.; Zamboglou, N.; Tsiliakos, S.; Hainoglou, D.; Mylonakis, N.; Pavlidis, Nicholas (1996)
      362 evaluable node-positive patients with stage II breast cancer were randomized, receiving either 6 cycles of conventional CMF or 6 cycles of the combination of cyclophosphamide (500 mg/m2), mitoxantrone (Novantrone 10 ...
    • Article  

      Prognostic variables in Greek patients with stage II breast cancer: A Hellenic Cooperative Oncology Group Study 

      Fountzilas, George; Vasilaros, S.; Koukouras, D.; Malamos, N.; Pectasides, Dimitrios; Adamou, A.; Nenopoulou, E.; Kiriakou, K.; Zouvani, I.; Katsohis, C.; Kappas, A. M.; Skopa, C.; Semoglou, C.; Fahantidis, E.; Konstantaras, C.; Vasilaki, E.; Economopoulos, T.; Bacoyiannis, Charalambos; Bafaloukos, Dimitrios; Razi, E. D.; Polichrnis, A.; Androulakis, G.; Papaioannou, T.; Pavlidis, Nicholas; Skarlos, Dimosthenis V.; Kosmidis, Paraskevas A. (1997)
      The independent effects of several patient, tumor and treatment-related prognostic factors on relapse-free survival (RFS) and overall survival (OS) were assessed by Cox multivariate regression analysis in 988 Greek patients ...